KLOW Stack
- Category
- Recovery & Healing
- Purpose
- Comprehensive Healing Across All Inflammation Phases
Why these peptides work together
KPV inhibits NF-κB nuclear translocation, suppressing TNF-α, IL-1β, and IL-6 production during the acute inflammatory phase — creating a calmer tissue environment before repair begins. BPC-157 and TB-500 then drive angiogenesis and cell migration during proliferation. GHK-Cu closes the loop with collagen and elastin synthesis during remodeling, while its antioxidant properties protect the newly formed tissue from oxidative damage throughout the process.
KPV calms inflammation first so the body isn't fighting itself, then BPC-157 and TB-500 do the heavy repair work, and GHK-Cu finishes by rebuilding the structural tissue — each peptide stepping in at the right phase.
⚠️ This page describes a combination of compounds that are, with few exceptions, not approved by the FDA for any use. It records protocols described in research and community sources. It is not a recommendation, not a prescription, and not medical advice. Combining compounds multiplies the unknowns rather than adding them. Do not act on anything here without a qualified healthcare professional who knows your history.